Abstract:Baculovirus has been widely used for the production of recombinant proteins in insect cells. The extremely high yield by baculovirus-infected insect cells or larvae makes it an attractive tool for pharmaceutical protein production. Since the finding that baculovirus can efficiently transduce mammalian cells, the applications of baculovirus have been greatly expanded. Although AcMNPV (Autographa californica multiple NPV) fails to replicate in vertebrate cells, it does express alien genes with levels of expression that are dependent on the strength of the promoter used to drive transcription of the foreign gene. Following these findings, subsequent studies have rapidly expanded the list of permissive cells that include cell lines originating from human, rodent, porcine, bovine and even fish sources. Many tries have been done to study the mechanism of baxulovirus entry into mammalian cells, but the events responsible for virus uptake and detailed mechanisms of intracellular movement and nuclear entry of the virus are still largely unknown. The application of modified baculoviruses for in vivo gene delivery has also been demonstrated. In contrast to other commonly used viral vectors, baculoviruses have the unique property of being incapable of initiating a replication cycle and producing infectious virus in mammalian cells. The AcMNPV genome is large, thus rendering the virus flexibility to carry multiple genes or large inserts. The recombinant viruses can be readily constructed and produced to high titers simply by infecting insect cells, initiate little to none microscopically observable cytopathic effects on mammalian cells and have a good biosafety profile. These attributes will undoubtedly lead to the increased application and continued development of this system for efficient gene delivery into mammalian cells.

Cloning and Expression of Baculovirus Ac108 Gene in Escherichia Coli

Construction of a Host Range-Expanded Hybrid Baculovirus of BmNPV and AcNPV, and Knockout of Cysteinase Gene for More Efficient Expression

Reduction of Polyhedrin Mrna and Protein Expression Levels in Sf9 and Hi5 Cell Lines, but Not in Sf21 Cells, Infected with Autographa Californica Multiple Nucleopolyhedrovirus Fp25k Mutants.

Characterization of Autographa Californica Multiple Nucleopolyhedrovirus ORF17.

Characterization of Bombyx Mori Nucleopolyhedrovirus with A Deletion of Bm118

Expression of Soluble H1N1 Haemegglutinin in Two Distinct Insect Baculovirus Expression Systems

Characterization of the Autographa Californica Nucleopolyhedrovirus Ubiquitin Gene Promoter.

Cloning, Expression and Characterization of a Novel Gene (P18) from Mycoplasma Bovis

Cell-Dependent Production Of Polyhedra And Virion Occlusion Of Autographa Californica Multiple Nucleopolyhedrovirus Fp25k Mutants In Vitro And In Vivo

A novel application of baculovirus in mammalian gene therapy]

Identification of Host Cell Protein Interacting with Envelope Protein GP64 of Autographa californica Multicapsid Nucleopolyhedrovirus

Expression of Nucleoprotein of Rabies Virus in Bac-To-Bac/AcMNPV Baculovirus Expression System

Expression of E2 Protein of Classical Swine Fever Virus Shimen Strain Using Baculovrius Expression System

Cloning, Construction of Prokaryotic Expression System and Identification of Vibrio Vulni Ficus Vvha Gene

Cloning and Expression of the Nucleoprotein Gene of Era Rabies Virus

Expression of Mouse Anti-human CD28 Single Chain Antibody Using Bombyx mori HyNPV Expression System

Immobilization of Foreign Protein in BmNPV Polyhedra by Fusion Expression with Partial Polyhedrin Fragments

Immobilization of Foreign Protein into BmNPV Polyhedra Through Fusion with Partial Polyhedrin Fragment

Genome-wide Nonessential Gene Identification of Autographa californica Multiple Nucleopolyhedrovirus

Enhanced virulence of genetically engineered Autographa californica nucleopolyhedrovirus owing to accelerated viral DNA replication aided by inserted ascovirus genes

Rapid Baculovirus Detection, Identification, and Serological Classification by Western Blotting-ELISA using a Monoclonal Antibody